Search

everythingexperts & clinicslearnfaqsresearchcommunity

for

Search:↓

The study suggests that CO₂ laser creates hair transplant channels with significantly less lateral thermal damage than Ho:YAG laser in the human scalp.

This article reviews four books on pediatric dermatopathology, photodamage, photoimmunology, and hair and scalp disorders, reporting no new research findings.

This pilot study observed that topical sildenafil 1% significantly increased vellus and terminal hair counts in female pattern hair loss patients, but did not improve hair thickness, while topical minoxidil 5% increased terminal hair count and thickness, making it the preferred treatment option.

This study reports that two phase III trials demonstrated the effectiveness of the oral Janus kinase inhibitor baricitinib at 2 mg or 4 mg daily for treating severe alopecia areata in adults, marking a potential advance in managing this condition.

This study found that dimethylpabamidopropyl laurdimonium tosylate, a quaternary ammonium surfactant, adsorbs onto human scalp hair with kinetic and isotherm behaviors fitting specific models, changing hair fiber wettability from hydrophobic to hydrophilic.

The researchers reported that a novel leave-on treatment containing caffeine, niacinamide, panthenol, dimethicone, and an acrylate polymer significantly increased the diameter and improved the mechanical properties of scalp hair fibers, suggesting it may help mitigate thinning hair.

This continuing medical education article outlines the comprehensive approach needed to diagnose alopecia, emphasizing the importance of a thorough history, scalp and hair examination, and, if necessary, laboratory analysis and biopsy for effective treatment planning.

In this study, the researchers developed and evaluated a polyherbal powder shampoo using Ayurvedic plants, concluding that formulation F3 effectively provides eco-friendly and safe hair care with antimicrobial properties, making it a promising alternative to synthetic shampoos.

In this study, Shikakai and Reetha, natural hair cleaning agents, were compared to chemical shampoos and found to be equally effective in cleaning hair, non-irritating to the scalp, biodegradable, inexpensive, and easy to use.

This study formulated and evaluated a herbal anti-dandruff shampoo using natural ingredients, finding that it effectively reduced dandruff, improved scalp and hair health, and presented an economical and safe alternative to synthetic shampoos without significant skin irritation.

This study evaluated the development of a herbal anti-dandruff shampoo using natural ingredients like fenugreek, curry leaves, and neem, finding it effective in reducing dandruff and nourishing the scalp without causing irritation, and suggesting it as a safe and economical alternative to synthetic shampoos.

This study evaluated three herbal powder shampoo formulations, reporting that Formulation 1, with a balance of cleansing and hydration, is most suitable for general scalp health and hair softness, while Formulation 3, with its higher cleansing power, is better for oily hair.

In this study, Ritlecitinib was reported as a newly approved treatment for alopecia areata that can be used in patients aged 12 and older; after 24 weeks, it resulted in 80% or more scalp hair coverage in treated patients compared to a placebo.

In this study, researchers found that cosmetic formulations containing guaraná extract effectively controlled oiliness in oily skin and hair by reducing sebaceous gland activity and lipid content without compromising skin barrier function, making them promising for managing excessive sebum production.

The researchers reported that finasteride prevents further hair loss in males with androgenetic alopecia by promoting hair growth, which helps maintain scalp coverage, but it is not effective for females.

This review discusses the use of zebrafish larvae as an alternative model for studying ototoxicity, facilitating large-scale screening for otoprotective compounds, but reports no new clinical results.

This study found that a polyherbal hair serum using Aloe vera, Amla, Bhringraj, Hibiscus, Rosemary, Argan, and Vitamin E showed promising results in reducing hair fall and improving scalp health, suggesting it may be a safe, natural alternative to synthetic products.

This paper discusses the challenges of hair transplantation in burn patients due to issues like scar tissue's mechanical properties, but reports no new clinical findings.

Mammalian hair scales change from smooth to wavy due to friction.

This study found no significant difference in effectiveness between 0.05% desonide cream and 1.0% hydrocortisone cream for treating seborrheic dermatitis over 8 weeks, with neither causing skin atrophy.

This case report documents acquired progressive kinking of the hair in a prepubertal boy but does not provide new clinical results.

This case report describes the trichoscopic and histological features observed in a 7-year-old boy with morphea en coup de sabre and details the positive response to systemic immunosuppressive therapy.

This article discusses Graham-Little Piccardi Lassueur Syndrome, a rare variant of Lichen planopilaris, but reports no clinical findings or results.

Minoxidil topical foam is a better, less irritating treatment for hair loss.

This study found that polarized light microscopy is more effective than diffractive microscopy in distinguishing scarring from non-scarring alopecia, providing a highly specific adjunct diagnostic tool for alopecia biopsy specimens.

Lichen Planopilaris causes irreversible hair loss due to immune attacks on hair stem cells, but modulating PPAR-γ might help treat it.

This report describes a rare case of epidermolysis bullosa acquisita in a child developing during therapy with squaric acid dibutyl ester for alopecia areata, suggesting a possible link between the medication and disease onset.

This case report documents the first known instance of Graham‐Little Piccardi Lassueur Syndrome in Saudi Arabia, observed in an adult dark-skinned male.

This research reported that the FDA approved Litfulo® (ritlecitinib) as the first oral treatment for severe alopecia areata in adolescents over 12 years old, with 23% of treated patients showing significant hair regrowth in clinical trials compared to 1.6% with placebo.

This study found that oxidative stress in hair follicle melanocytes contributes to premature aging and apoptosis, providing insights into graying as a model for studying aging and testing antiaging therapies.